Park Medi World Acquires Krishna Super-speciality Hospital for ₹40 Crore
Park Medi World Limited acquired Krishna Super-speciality Hospital for ₹40 crore. The 250-bedded hospital is owned by Mahip Hospitals Private Limited. This acquisition is part of Park Group's strategy to expand its bed capacity to 5,260 by March 2028. The deal was approved by the board on January 05, 2026.
The acquisition of a 250-bedded super-speciality hospital is a significant corporate action that will materially impact the company's scale of operations, revenue, and market presence.
The acquisition of a hospital is a positive development that expands the company's operational capacity and strengthens its market position, aligning with its long-term growth strategy.
Park Medi World Limited announced today, January 05, 2026, that its Board of Directors has approved the acquisition of the entire existing shareholding of Krishna Super-speciality Hospital, which is owned by Mahip Hospitals Private Limited.
The acquisition marks a significant strategic move for Park Medi World Limited. Krishna Super-speciality Hospital, a 250-bedded facility with 70 ICU beds, is strategically located in Bathinda, serving as a key healthcare hub for both urban and rural populations.
The company has been managing the operations of this hospital since July 2025 and has now completed the 100% shareholding acquisition from the current promoters for a cash consideration of ₹40 crore. This acquisition is expected to strengthen Park Group's infrastructure and support its plan to reach a total of 5,260 beds by March 2028.
Mahip Hospitals Private Limited has an authorized capital of ₹15 lacs and a paid-up capital of ₹13.5 lacs. The acquired entity operates in the hospital industry and provides comprehensive medical care across super-specialties including Cardiac Sciences, Neurosciences, Oncology, and Orthopaedics. Its turnover for the last three fiscal years was Nil for FY 2022-23, ₹7.73 crore for FY 2023-24, and ₹16.00 crore for FY 2024-25.
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.